February 27, 2015 3:08 AM ET


Company Overview of Implicit Bioscience Limited

Company Overview

Implicit Bioscience Ltd. operates as a clinical-stage drug development company. It develops drugs that modulate the host immune response to disease. The company is developing the small molecule dipeptide oglufanide disodium for a range of community and hospital-acquired infections, including those caused by a variety of biothreat agents. Implicit Bioscience’s IC14 is a clinical stage recombinant chimeric monoclonal antibody, which recognizes and blocks the function of human CD14, a component of the innate inflammatory response to bacterial infection. The company was founded in 2004 and is based in Toowong, Australia with additional operations in Brisbane, Australia; and Seattle, Washington.

80 Jephson Street

Data 3 House

Level 1

Toowong, QLD 4066


Founded in 2004


61 7 3721 1242


61 7 3719 5499

Key Executives for Implicit Bioscience Limited

Chief Executive Officer, Managing Director and Executive Director
Co-Founder and Director of Strategy
Chief Financial Officer and Company Secretary
Chief Business Officer and Executive Director
Vice President of Product Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
TGR Biosciences Pty Ltd Asia
Bioactive Laboratories Pty Ltd. Asia
DelvTech Int. Pty Ltd. Asia
CSL Bioplasma Ltd. Asia
Chemgenex Pharmaceuticals Ltd. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Implicit Bioscience Limited, please visit www.implicitbioscience.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.